Terms: = Breast cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
64 results:
1. TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of breast cancer: Potential Therapeutic Targets.
Salmerón-Bárcenas EG; Zacapala-Gómez AE; Torres-Rojas FI; Antonio-Véjar V; Ávila-López PA; Baños-Hernández CJ; Núñez-Martínez HN; Dircio-Maldonado R; Martínez-Carrillo DN; Ortiz-Ortiz J; Jiménez-Wences H
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203443
[TBL] [Abstract] [Full Text] [Related]
2. In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice.
Li BE; Li GY; Cai W; Zhu Q; Seruggia D; Fujiwara Y; Vakoc CR; Orkin SH
Blood Adv; 2023 Sep; 7(18):5281-5293. PubMed ID: 37428871
[TBL] [Abstract] [Full Text] [Related]
3. Clonal Hematopoiesis in Young Women Treated for breast cancer.
Gibson CJ; Fell G; Sella T; Sperling AS; Snow C; Rosenberg SM; Kirkner G; Patel A; Dillon D; Bick AG; Neuberg D; Partridge AH; Miller PG
Clin Cancer Res; 2023 Jul; 29(13):2551-2558. PubMed ID: 37115512
[TBL] [Abstract] [Full Text] [Related]
4. Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing.
Fairchild L; Whalen J; D'Aco K; Wu J; Gustafson CB; Solovieff N; Su F; Leary RJ; Campbell CD; Balbin OA
Sci Transl Med; 2023 Mar; 15(689):eabm8729. PubMed ID: 36989374
[TBL] [Abstract] [Full Text] [Related]
5. Glyphosate disturbs various epigenetic processes in vitro and in vivo - A mini review.
Bukowska B; Woźniak E; Sicińska P; Mokra K; Michałowicz J
Sci Total Environ; 2022 Dec; 851(Pt 2):158259. PubMed ID: 36030868
[TBL] [Abstract] [Full Text] [Related]
6. Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers.
Lemma RB; Fleischer T; Martinsen E; Ledsaak M; Kristensen V; Eskeland R; Gabrielsen OS; Mathelier A
Epigenetics Chromatin; 2022 Apr; 15(1):13. PubMed ID: 35440061
[TBL] [Abstract] [Full Text] [Related]
7. tet2-mediated epigenetic reprogramming of breast cancer cells impairs lysosome biogenesis.
Laurent A; Madigou T; Bizot M; Turpin M; Palierne G; Mahé E; Guimard S; Métivier R; Avner S; Le Péron C; Salbert G
Life Sci Alliance; 2022 Jul; 5(7):. PubMed ID: 35351824
[TBL] [Abstract] [Full Text] [Related]
8. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
[TBL] [Abstract] [Full Text] [Related]
9. tet2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling.
Zhang X; Li S; He J; Jin Y; Zhang R; Dong W; Lin M; Yang Y; Tian T; Zhou Y; Xu Y; Lei QY; Zhang J; Zhang Q; Xu Y; Lv L
Cancer Res; 2022 Jun; 82(11):2097-2109. PubMed ID: 35176127
[TBL] [Abstract] [Full Text] [Related]
10. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
11. Regulation of tet2 gene expression and 5mC oxidation in breast cancer cells by estrogen signaling.
Zhu X; Xiong L; Lyu R; Shen Y; Liu L; Li S; Argueta C; Tan L
Biochem Biophys Res Commun; 2022 Jan; 589():240-246. PubMed ID: 34929447
[TBL] [Abstract] [Full Text] [Related]
12. Tumour suppressor tet2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells.
Lyu R; Zhu X; Shen Y; Xiong L; Liu L; Liu H; Wu F; Argueta C; Tan L
Epigenetics; 2022 Oct; 17(10):1180-1194. PubMed ID: 34689714
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation.
Sklias A; Halaburkova A; Vanzan L; Jimenez NF; Cuenin C; Bouaoun L; Cahais V; Ythier V; Sallé A; Renard C; Durand G; Le Calvez-Kelm F; Khoueiry R; Murr R; Herceg Z
Nucleic Acids Res; 2021 Sep; 49(17):9738-9754. PubMed ID: 34403459
[TBL] [Abstract] [Full Text] [Related]
14. Next generation sequencing in therapy-related myeloid neoplasms compared to
Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
[TBL] [Abstract] [Full Text] [Related]
15. tet2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract] [Full Text] [Related]
16. Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of breast cancer in Australian Caucasian Women.
Arif KMT; Bradshaw G; Nguyen TTN; Smith RA; Okolicsanyi RK; Youl PH; Haupt LM; Griffiths LR
Clin Breast Cancer; 2021 Dec; 21(6):e694-e703. PubMed ID: 33952417
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases.
Chao X; Tan W; Tsang JY; Tse GM; Hu J; Li P; Hou J; Li M; He J; Sun P
Breast Cancer; 2021 Sep; 28(5):1100-1111. PubMed ID: 33942253
[TBL] [Abstract] [Full Text] [Related]
18. Exploring effects of DNA methylation and gene expression on pan-cancer drug response by mathematical models.
Lv W; Zhang X; Dong H; Wu Q; Sun B; Zhang Y
Exp Biol Med (Maywood); 2021 Jul; 246(14):1626-1642. PubMed ID: 33910405
[TBL] [Abstract] [Full Text] [Related]
19. A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3-Specific CAR T Cells in Solid Tumors.
Lei X; Ou Z; Yang Z; Zhong J; Zhu Y; Tian J; Wu J; Deng H; Lin X; Peng Y; Li B; He L; Tu Z; Chen W; Li Q; Liu N; Zhang H; Wang Z; Fang Z; Yamada T; Lv X; Tian T; Pan G; Wu F; Xiao L; Zhang L; Cai T; Wang X; Tannous BA; Li J; Kontos F; Ferrone S; Fan S
Clin Cancer Res; 2021 Jul; 27(13):3757-3771. PubMed ID: 33811153
[TBL] [Abstract] [Full Text] [Related]
20. Genome-wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in breast cancer.
Wu SL; Zhang X; Chang M; Huang C; Qian J; Li Q; Yuan F; Sun L; Yu X; Cui X; Jiang J; Cui M; Liu Y; Wu HW; Liang ZY; Wang X; Niu Y; Tong WM; Jin F
Genomics Proteomics Bioinformatics; 2021 Feb; 19(1):64-79. PubMed ID: 33716151
[TBL] [Abstract] [Full Text] [Related]
[Next]
